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Objective: To assess global thrombotic status in patients with end-stage renal disease (ESRD) and relate this to the risk of peripheral arterial or 
arterio-venous (AV) fistula thrombosis.
Background: ESRD patients have an excess thrombotic risk, above that predicted by traditional risk factor models. In addition to cardiovascular 
events, fistula thrombosis is a major cause of morbidity in this group. Prothrombotic status may contribute to this increased risk. Global thrombotic 
status assessment, including measurement of platelet reactivity and thrombolytic status, may identify vulnerable patients.
Methods: Thrombotic and thrombolytic status of ESRD patients (n=216) established on hemodialysis was assessed using the Global Thrombosis 
Test, and compared to that of healthy controls. This novel, near-patient test measures the time required to form and time required to lyse an 
occlusive platelet thrombus (occlusion time, OT and lysis time, LT). Patients were followed up for 276.1±166 days for peripheral arterial or AV fistula 
thrombosis.
Results: Platelet reactivity was reduced (OT 490.7±176.5s vs. 377.8±96.0s, P<0.001) and endogenous thrombolysis was impaired (LT median 
1820.0s vs.1052.5s, P<0.001) in ESRD compared to normal subjects. LT≥3000s occurred in 42% of ESRD patients, and none of the controls. 
Impaired endogenous thrombolysis (LT≥3000s) was highly predictive of peripheral thrombosis (HR 9.08, 95% CI 2.08-39.75, P=0.003), independent 
of traditional risk factors. No association was found between OT and thrombotic events.
Conclusions: Impaired endogenous thrombolysis is a novel risk factor in ESRD, predictive of a high risk of peripheral thrombotic events.
